Rajan Sharma
Stock Analyst at Goldman Sachs
(0.11)
# 4,451
Out of 5,102 analysts
5
Total ratings
25%
Success rate
-30.02%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Rajan Sharma
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DBVT DBV Technologies | Reinstates: Sell | $7.25 | $19.60 | -63.01% | 1 | May 29, 2025 | |
| AZN AstraZeneca | Initiates: Buy | $97 | $90.62 | +7.04% | 1 | May 30, 2024 | |
| GSK GSK plc | Initiates: Neutral | $47 | $48.67 | -3.43% | 1 | May 30, 2024 | |
| IMCR Immunocore Holdings | Reiterates: Overweight | $79 | $36.00 | +119.44% | 2 | Jun 20, 2023 |
DBV Technologies
May 29, 2025
Reinstates: Sell
Price Target: $7.25
Current: $19.60
Upside: -63.01%
AstraZeneca
May 30, 2024
Initiates: Buy
Price Target: $97
Current: $90.62
Upside: +7.04%
GSK plc
May 30, 2024
Initiates: Neutral
Price Target: $47
Current: $48.67
Upside: -3.43%
Immunocore Holdings
Jun 20, 2023
Reiterates: Overweight
Price Target: $79
Current: $36.00
Upside: +119.44%